Cargando…
Caveolin-1 and MLRs: A potential target for neuronal growth and neuroplasticity after ischemic stroke
Ischemic stroke is a leading cause of morbidity and mortality worldwide. Thrombolytic therapy, the only established treatment to reduce the neurological deficits caused by ischemic stroke, is limited by time window and potential complications. Therefore, it is necessary to develop new therapeutic st...
Autores principales: | Zhong, Wei, Huang, Qianyi, Zeng, Liuwang, Hu, Zhiping, Tang, Xiangqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818210/ https://www.ncbi.nlm.nih.gov/pubmed/31673241 http://dx.doi.org/10.7150/ijms.35158 |
Ejemplares similares
-
A review of the role of cav-1 in neuropathology and neural recovery after ischemic stroke
por: Huang, Qianyi, et al.
Publicado: (2018) -
Potential Neuroprotective Treatment of Stroke: Targeting Excitotoxicity, Oxidative Stress, and Inflammation
por: Yang, Qianwen, et al.
Publicado: (2019) -
Angiogenesis, Neurogenesis and Neuroplasticity in Ischemic Stroke
por: Font, M. Angels, et al.
Publicado: (2010) -
Oxidative Stress, Inflammation, and Autophagy: Potential Targets of Mesenchymal Stem Cells-Based Therapies in Ischemic Stroke
por: He, Jialin, et al.
Publicado: (2021) -
Targeting phosphodiesterase 4 as a potential therapeutic strategy for enhancing neuroplasticity following ischemic stroke
por: Wang, Haitao, et al.
Publicado: (2018)